SELECT-PsA2 group refractory to prior bDMARD therapy UPA - useful oral JAKi option in Psoriatic Arthritis Safety consistent with what we know from RA. More Sfx at 30mg. No clear VTE signal #ACR20 https://t.co/XpprRprugI